KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Moderna (MRNA) over the last 6 years, with Dec 2024 value amounting to $384.0 million.

  • Moderna's Shares Outstanding (Diluted Average) fell 2.26% to $390.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $390.0 million, marking a year-over-year decrease of 2.26%. This contributed to the annual value of $384.0 million for FY2024, which is 0.52% up from last year.
  • Moderna's Shares Outstanding (Diluted Average) amounted to $384.0 million in FY2024, which was up 0.52% from $382.0 million recorded in FY2023.
  • Moderna's 5-year Shares Outstanding (Diluted Average) high stood at $431.0 million for FY2021, and its period low was $381.0 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $384.0 million (2024), whereas its average is $394.0 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first rose by 15.11% in 2020, then decreased by 8.17% in 2023.
  • Moderna's Shares Outstanding (Diluted Average) (Yearly) stood at $381.0 million in 2020, then increased by 13.12% to $431.0 million in 2021, then declined by 3.48% to $416.0 million in 2022, then declined by 8.17% to $382.0 million in 2023, then climbed by 0.52% to $384.0 million in 2024.